Inspire Medical Systems, Inc. Payments to Acquire Investments
Inspire Medical Systems, Inc. (INSP) reported Payments to Acquire Investments of $9.99 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-15.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquireInvestments · last filed 2022-02-15
- Inspire Medical Systems, Inc. payments to acquire investments for the quarter ending 2021-12-31 was $0.00.
- Inspire Medical Systems, Inc. payments to acquire investments for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. payments to acquire investments for the quarter ending 2021-06-30 was $9.99M.
- Inspire Medical Systems, Inc. payments to acquire investments for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. payments to acquire investments for fiscal 2021 was $9.99M, a 81.05% decline from fiscal 2020.
- Inspire Medical Systems, Inc. payments to acquire investments for fiscal 2020 was $52.72M, a 70.39% decline from fiscal 2019.
- Inspire Medical Systems, Inc. payments to acquire investments for fiscal 2019 was $178.07M, a 54.20% increase from fiscal 2018.
- Inspire Medical Systems, Inc. payments to acquire investments for fiscal 2018 was $115.48M, a 1187.56% increase from fiscal 2017.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $9.99M derived: sum of 3 quarters · filed 2022-02-15 | $9.99M 10-K · filed 2022-02-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $9.99M derived: sum of 2 quarters · filed 2021-11-02 | $9.99M 10-Q · filed 2021-11-02 | $9.99M derived: sum of 4 quarters · filed 2022-02-15 |
| 2021-06-30 | $9.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $9.99M 10-Q · filed 2021-08-03 | $9.99M derived: sum of 3 quarters · filed 2022-02-15 | $47.81M derived: sum of 4 quarters · filed 2022-02-15 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | $0.00 derived: sum of 2 quarters · filed 2022-02-15 | $37.81M derived: sum of 3 quarters · filed 2022-02-15 | $37.81M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $37.81M derived: sum of 2 quarters · filed 2022-02-15 | $37.81M derived: sum of 3 quarters · filed 2022-02-15 | $52.72M 10-K · filed 2022-02-15 |
| 2020-09-30 | $37.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $37.81M derived: sum of 2 quarters · filed 2021-11-02 | $52.72M 10-Q · filed 2021-11-02 | $87.27M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $14.91M 10-Q · filed 2021-08-03 | $49.46M derived: sum of 3 quarters · filed 2022-02-15 | $91.94M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $14.91M 10-Q · filed 2021-05-04 | $49.46M derived: sum of 2 quarters · filed 2022-02-15 | $91.94M derived: sum of 3 quarters · filed 2022-02-15 | $152.41M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $34.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $77.04M derived: sum of 2 quarters · filed 2022-02-15 | $137.50M derived: sum of 3 quarters · filed 2022-02-15 | $178.07M 10-K · filed 2022-02-15 |
| 2019-09-30 | $42.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $102.95M derived: sum of 2 quarters · filed 2020-11-02 | $143.52M 10-Q · filed 2020-11-02 | $160.07M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $60.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $101.04M 10-Q · filed 2020-08-04 | $117.58M derived: sum of 3 quarters · filed 2021-02-24 | $211.38M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $40.57M 10-Q · filed 2020-05-05 | $57.12M derived: sum of 2 quarters · filed 2021-02-24 | $150.92M derived: sum of 3 quarters · filed 2021-02-24 | $151.41M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $16.55M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $110.34M derived: sum of 2 quarters · filed 2021-02-24 | $110.84M derived: sum of 3 quarters · filed 2021-02-24 | $115.48M 10-K · filed 2021-02-24 |
| 2018-09-30 | $93.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $94.29M derived: sum of 2 quarters · filed 2019-11-05 | $98.94M 10-Q · filed 2019-11-05 | $103.10M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $496.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $5.14M 10-Q · filed 2019-08-06 | $9.30M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2018-03-31 | $4.64M 10-Q · filed 2019-05-07 | $8.81M derived: sum of 2 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $8.97M 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $4.80M 10-Q · filed 2018-11-06 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |